Mallinckrodt plc

(OTC:MNKKQ)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Mallinckrodt PLC develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands that includes innovative specialty pharmaceutical brands; and Specialty Generics that includes niche specialty generic drugs and active pharmaceutical ingredients.

Contact Information

Website: www.mallinckrodt.com
Email: investor.relations@mnk.com
Main Phone: +44 1784636700
Address: 3 Lotus Park, The Causeway
Address 2: Cruiserath
State: Surrey
City / Town: Staines-Upon-Thames
Country: GB
Postal Code: TW18 3AG

Issuer Information

Exchange: OTO
CEO: Mark C. Trudeau
Employees: 3400
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A